{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:40:38Z","timestamp":1760607638683,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Anesthesia"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.jclinane.2016.05.008","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T23:00:30Z","timestamp":1465426830000},"page":"407-411","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["In vitro antimicrobial activity of commonly used vasoactive drugs"],"prefix":"10.1016","volume":"34","author":[{"given":"Ozgun","family":"Cuvas Apan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teoman Zafer","family":"Apan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alparslan","family":"Apan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jclinane.2016.05.008_bb0005","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00003246-200204000-00019","article-title":"Unexpected high risk of contamination with staphylococci species attributable to standard preparation of syringes for continuous intravenous drug administration in a simulation model in intensive care units","volume":"30","author":"Van Grafhorst","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0010","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s00134-010-1775-y","article-title":"Analysis of particulate contaminations of infusion solutions in a pediatric intensive care","volume":"36","author":"Jack","year":"2010","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhin.2010.12.015","article-title":"Non-return valves do not prevent backflow and bacterial contamination of intravenous infusions","volume":"78","author":"Ellger","year":"2011","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0020","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/S0140-6736(03)13644-6","article-title":"Nosocomial infections in adult intensive-care units","volume":"361","author":"Vincent","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0025","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1001\/jama.1995.03530080055041","article-title":"The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee","volume":"274","author":"Vincent","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0030","first-page":"548","article-title":"The effect of antiseptic solution in central venous catheter care","volume":"113","author":"Atahan","year":"2012","journal-title":"Bratisl Lek Listy"},{"issue":"Suppl. 1","key":"10.1016\/j.jclinane.2016.05.008_bb0035","first-page":"45","article-title":"Bacteriology, safety and prevention of infection associated with continuous intravenous infusions","volume":"7","author":"Mermel","year":"1996","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0040","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yrtph.2005.01.010","article-title":"The prooxidant effect of sodium metabisulfite in rat liver and kidney","volume":"42","author":"Elmas","year":"2005","journal-title":"Regul Toxicol Pharmacol"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0045","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/j.2042-7158.1972.tb08939.x","article-title":"Interaction between sodium metabisulphite and PMN","volume":"24","author":"Richards","year":"1972","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.burns.2007.07.004","article-title":"Impairment of the host's antibacterial resistance by norepinephrine activated neutrophils","volume":"34","author":"Tsuda","year":"2008","journal-title":"Burns"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0055","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/JB.01028-09","article-title":"Elucidation of the mechanism by which catecholamine stress hormones liberate iron from the innate immune defense proteins transferrin and lactoferrin","volume":"192","author":"Sandrini","year":"2010","journal-title":"J Bacteriol"},{"key":"10.1016\/j.jclinane.2016.05.008_bb0060","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1128\/AAC.01158-09","article-title":"Neutrophil gelatinase-associated lipocalin expresses antimicrobial activity by interfering with L-norepinephrine\u2013mediated bacterial iron acquisition","volume":"54","author":"Miethke","year":"2010","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Clinical Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818016301921?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952818016301921?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:09:06Z","timestamp":1760605746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952818016301921"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":12,"alternative-id":["S0952818016301921"],"URL":"https:\/\/doi.org\/10.1016\/j.jclinane.2016.05.008","relation":{},"ISSN":["0952-8180"],"issn-type":[{"type":"print","value":"0952-8180"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In vitro antimicrobial activity of commonly used vasoactive drugs","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jclinane.2016.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}